Ceesay Abraham
CIK 0001722140
PresidentDirector
Filings
17
Latest May 11, 2026
Issuers covered
4
Showing
17 of 17
Page 1
Track record
25 of 25 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 25 | 76% | +1.3% | +5.5% | +10.7% | -15.5% |
| 90 days | 25 | 28% | -11.1% | -15.7% | +9.5% | -43.0% |
| 180 days | 13 | 8% | -23.1% | -34.4% | +17.3% | -40.1% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Ceesay Abraham has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 9 | Feb 19, 2026 |
| PCRX | Pacira Biosciences, Inc. | 4 | Sep 8, 2025 |
| CRL | Charles River Laboratories International, Inc. | 2 | May 11, 2026 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 2 | Feb 8, 2023 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|